The authors developed a real-time and label-free approach based on quantitative phase imaging to determine drug sensitivity with significant advantages over endpoint viability or metabolic assays, and which reveals single cell response heterogeneity.
- Edward R. Polanco
- Tarek E. Moustafa
- Thomas A. Zangle
